000 nab a22 7a 4500
999 _c17614
_d17614
003 PC17614
005 20230725135534.0
008 230725b xxu||||| |||| 00| 0 eng d
040 _cH12O
041 _aeng
100 _92596
_aAlfaro, Javier
_eInstituto de Investigación i+12
100 _92937
_aPérez Méndez, Dolores
_eInmunología
100 _9358
_aJiménez Romero, Carlos
_eCirugía General y del Aparato Digestivo
100 _92597
_aMartinez-Flores, Jose A.
_eInstituto de Investigación i+12
100 _91105
_aGrau Sanz, Montserrat
_eCirugía General y del Aparato Digestivo
100 _92462
_aSánchez Zapardiel, Elena
_eInmunología
100 _91510
_aPaz Artal, Estela
_eInmunología
100 _9661
_aSerrano Hernández, Antonio
_eInmunología
245 0 0 _aBlockade of cell adhesion molecules enhances cell engraftment in a murine model of liver cell transplantation.
_h[artículo]
260 _bTransplant immunology,
_c2016
300 _a35:7-11.
500 _aFormato Vancouver: Alfaro J, Pérez D, Jiménez C, Serrano M, Martínez Flores JÁ, Grau M et al. Blockade of cell adhesion molecules enhances cell engraftment in a murine model of liver cell transplantation. Transpl Immunol. 2016 Mar;35:7-11.
501 _aPMID: 26875547
504 _aContiene 34 referencias
520 _aAim: OLT is the best alternative for patients with end-stage liver diseases. However, as the need for organs surpasses donor availability, alternatives to OLT are required. LCT could be a useful option versus OLT in several patients even though its low cell-engraftment hampers its efficiency. Endothelial cell barrier is the main obstacle for the implantation of cells into the parenchyma. Our study has focused on the modification of the endothelial barrier with monoclonal antibodies against adhesion molecules in order to increase cell engraftment in a mouse model of liver cell transplantation. Methods: Anti-mouse CD54 and anti-mouse CD61 antibodies were administered intrasplenically to healthy mice within 60 min prior to stem cell transplantation. Animals were sacrificed either short term at 2h or middle term seven days after transplantation. Immunohistochemical techniques to detect alkaline phosphatase activity were used to identify the transplanted cells within the liver parenchyma. Results: Anti-CD54 and anti-CD61 administration increases vascular patency and cell engraftment. This represents a 32% and 45% increase, respectively, of engrafted cells compared to the control (p<0.05). Conclusion: Modification of the vascular wall with monoclonal antibodies against endothelial adhesion molecules before cell transplantation enhances cell engraftment into the mouse liver.
710 _9625
_aInstituto de Investigación imas12
710 _9395
_aServicio de Inmunología
710 _9271
_aServicio de Cirugía General y del Aparato Digestivo
856 _uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc17614.pdf
_ySolicitar documento
942 _2ddc
_cART
_n0